From the Alzheimer Center and the Neuroscience Campus Amsterdam, and Departments of Radiology and Nuclear Medicine (H.I.Z., M.P.W., F.B.), Neurology (J.D.C.G., N.D.P., P.S., W.M.v.d.F.), Epidemiology and Biostatistics (W.M.v.d.F.), Physics and Medical Technology (J.P.A.K.), and Internal Medicine (M.M.), VU University Medical Center, Amsterdam, the Netherlands.
Neurology. 2014 Feb 25;82(8):698-704. doi: 10.1212/WNL.0000000000000150. Epub 2014 Jan 29.
To determine prevalence, topography, and severity of cortical superficial siderosis (SS), a recently recognized manifestation of cerebral amyloid angiopathy, and its possible association with Alzheimer disease (AD) in a memory clinic patient cohort.
We included 809 patients (56% men, aged 66 ± 10 years) from the Amsterdam Dementia Cohort between November 2010 and November 2012 scanned on a 3-tesla MRI system. We analyzed prevalence and topography of cortical SS according to demographic, clinical, and MRI data. Agreement for SS detection between 2 neuroradiologists was calculated by using Cohen κ.
Agreement for detection of SS was excellent (unweighted κ of 0.81). In 17 patients (2.1%), cortical SS was found without a known cause. The prevalence of idiopathic SS differed according to diagnostic groups (p < 0.001): nearly 5% (95% confidence interval [CI] 2.8%-8.2%) in patients with AD (n = 168) vs 2% (95% CI 0.7%-6.0%) in patients with mild cognitive impairment (n = 143) and 2.5% (95% CI 0.7%-8.7%) in other types of dementia (n = 80). By contrast, SS was not found in patients with subjective complaints (n = 168) or in those with other disorders (n = 157). Presence of SS was associated with APOE ε4, microbleeds, and white matter hyperintensities (all p < 0.05) independent of diagnosis.
The prevalence of cortical SS in a memory clinic setting is higher than reported in the general population but lower than reported in cerebral amyloid angiopathy. The relatively high prevalence of SS in AD suggests that SS is a relevant radiologic manifestation of amyloid pathology in AD. Presence of SS does not seem to predict severity of AD. Further longitudinal research is needed to investigate clinical relevance.
确定皮质浅层铁沉积(SS)的患病率、分布和严重程度,这是一种最近被认识到的脑淀粉样血管病表现,并在记忆诊所患者队列中研究其与阿尔茨海默病(AD)的可能关联。
我们纳入了 2010 年 11 月至 2012 年 11 月在 3T MRI 系统上扫描的 809 名(56%为男性,年龄 66±10 岁)阿姆斯特丹痴呆队列患者。我们根据人口统计学、临床和 MRI 数据分析皮质 SS 的患病率和分布。使用 Cohen κ 计算两位神经放射学家对 SS 检测的一致性。
SS 的检测一致性极好(未加权 κ 值为 0.81)。在 17 名(2.1%)患者中,发现了无已知原因的皮质 SS。特发性 SS 的患病率因诊断组而异(p<0.001):在 AD 患者(n=168)中为近 5%(95%置信区间[CI] 2.8%-8.2%),在轻度认知障碍患者(n=143)中为 2%(95%CI 0.7%-6.0%),在其他类型痴呆患者(n=80)中为 2.5%(95%CI 0.7%-8.7%)。相比之下,在有主观抱怨的患者(n=168)或有其他疾病的患者(n=157)中未发现 SS。SS 的存在与 APOE ε4、微出血和白质高信号(均 p<0.05)有关,独立于诊断。
在记忆诊所环境中,皮质 SS 的患病率高于一般人群报告的患病率,但低于脑淀粉样血管病报告的患病率。AD 中 SS 的相对较高患病率表明 SS 是 AD 中淀粉样病理学的一个相关放射学表现。SS 的存在似乎并不能预测 AD 的严重程度。需要进一步的纵向研究来探讨其临床相关性。